Dáil Éireann Debate, Tuesday - 8 November 2016
368. Deputy Ruth Coppinger asked the Minister for Health when the FreeStyle Libre flash glucose monitoring system will become available for public patients; and if he will make a statement on the matter. [33614/16]
View answerThe HSE has statutory responsibility for decisions on pricing and reimbursement of medicinal products and devices under the community drug schemes in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013.
The manufacturer must make a completed application to the HSE for reimbursement of the device under the community drugs schemes. A health technology assessment may then be required to assess its clinical benefits and cost-effectiveness.
